GlobeNewswire Inc.··Zealand Pharma A/SZealand Pharma Surges on Obesity Drug Breakthroughs and $700M Revenue Milestone
Zealand Pharma reports strong Q1 2026 results with obesity treatment advances, $700M collaboration revenue, and $200M share buyback program.
RHHBYZLDPYPhase 3 trialsclinical trial results